Researcher Profile

Researcher Profile

Qiushi Chen

Qiushi Chen

Assistant Professor, Marcus Department of Industrial and Manufacturing Engineering
Scientific Program:Cancer Control

Research Interests

  • Therapeutics
  • Cost-Benefit Analysis
  • Hepatitis C
  • Hepacivirus
  • Costs and Cost Analysis
  • Antiviral Agents
  • Quality-Adjusted Life Years
  • Colorectal Neoplasms
  • Lymphoma, Large B-Cell, Diffuse
  • Drug Therapy
  • Population
  • Rituximab

Recent Publications


Adee, M, Zhuo, Y, Zhan, T, Chen, Q, Toumi, A, Ayer, T, Nwankwo, C, Zhong, H, Puenpatom, A & Chhatwal, J 2021, 'A Tool to Inform Hepatitis C Elimination: A Case for Hepatitis C Elimination in China', Clinical Liver Disease, vol. 17, no. 3, pp. 99-106.


Chen, Q, Ayer, T, Adee, MG, Wang, X, Kanwal, F & Chhatwal, J 2020, 'Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma among Patients with Hepatitis C in the Era of Direct-Acting Antiviral Agents', JAMA network open, vol. 3, no. 11, e2021173.
Chen, S, Chen, Q, Yang, W, Xue, L, Liu, Y, Yang, J, Wang, C & Bärnighausen, T 2020, 'Buying Time for an Effective Epidemic Response: The Impact of a Public Holiday for Outbreak Control on COVID-19 Epidemic Spread', Engineering, vol. 6, no. 10, pp. 1108-1114.
Zhuo, Y, Hayashi, T, Chen, Q, Aggarwal, R, Hutin, Y & Chhatwal, J 2020, 'Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan', Scientific reports, vol. 10, no. 1, 4089.


Çağlayan, Ç, Terawaki, H, Ayer, T, Goldstein, JS, Rai, A, Chen, Q & Flowers, C 2019, 'Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate Model', Clinical Lymphoma, Myeloma and Leukemia, vol. 19, no. 5, pp. 300-309.e5.
Chhatwal, J, Chen, Q, Wang, X, Ayer, T, Zhuo, Y, Janjua, NZ & Kanwal, F 2019, 'Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan', JAMA network open, vol. 2, no. 5, pp. e193613.
Chen, Q, Ayer, T, Bethea, E, Kanwal, F, Wang, X, Roberts, M, Zhuo, Y, Fagiuoli, S, Petersen, J & Chhatwal, J 2019, 'Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: A modelling study', BMJ open, vol. 9, no. 6, e026726.
Chen, Q, Larochelle, MR, Weaver, DT, Lietz, AP, Mueller, PP, Mercaldo, S, Wakeman, SE, Freedberg, KA, Raphel, TJ, Knudsen, AB, Pandharipande, PV & Chhatwal, J 2019, 'Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States', JAMA network open, vol. 2, no. 2, pp. e187621.
Chhatwal, J, Chen, Q, Bethea, ED, Hur, C, Spaulding, AC & Kanwal, F 2019, 'The impact of direct-acting anti-virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States', Alimentary Pharmacology and Therapeutics, vol. 50, no. 1, pp. 66-74.


Goel, A, Chen, Q, Chhatwal, J & Aggarwal, R 2018, 'Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment', Journal of Gastroenterology and Hepatology (Australia), vol. 33, no. 12, pp. 2029-2036.
Chen, Q, Zhao, L, Fransoo, JC & Li, Z 2019, 'Dual-mode inventory management under a chance credit constraint', OR Spectrum, vol. 41, no. 1, pp. 147-178.
Chhatwal, J, Chen, Q & Aggarwal, R 2018, 'Estimation of Hepatitis C Disease Burden and Budget Impact of Treatment Using Health Economic Modeling', Infectious Disease Clinics of North America, vol. 32, no. 2, pp. 461-480.
Chen, Q, Staton, AD, Ayer, T, Goldstein, DA, Koff, JL & Flowers, CR 2018, 'Exploring the potential cost-effectiveness of precision medicine treatment strategies for diffuse large B-cell lymphoma', Leukemia and Lymphoma, vol. 59, no. 7, pp. 1700-1709.
Chhatwal, J, Chen, Q, Bethea, ED, Ladd, MA, Mueller, PP, Hutin, Y & Aggarwal, R 2018, 'Hep C Calculator: an online tool for cost-effectiveness analysis of DAAs', The Lancet Gastroenterology and Hepatology, vol. 3, no. 12.
Chhatwal, J, Chen, Q, Ayer, T, Bethea, ED, Kanwal, F, Kowdley, KV, Wang, X, Roberts, MS & Gordon, SC 2018, 'Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA', Alimentary Pharmacology and Therapeutics, vol. 47, no. 7, pp. 1023-1031.
Çağlayan, Ç, Terawaki, H, Chen, Q, Rai, A, Ayer, T & Flowers, CR 2018, 'Microsimulation modeling in oncology', JCO Clinical Cancer Informatics, vol. 2018, no. 2, pp. 1-11.
Chen, Q, Ayer, T & Chhatwal, J 2018, 'Optimal M-switch surveillance policies for liver cancer in a hepatitis C-infected population', Operations Research, vol. 66, no. 3, pp. 673-696.
Bethea, ED, Chen, Q, Hur, C, Chung, RT & Chhatwal, J 2018, 'Reply', Hepatology, vol. 67, no. 4, pp. 1641-1642.
Bethea, ED, Chen, Q, Hur, C, Chung, RT & Chhatwal, J 2018, 'Should we treat acute hepatitis C? A decision and cost-effectiveness analysis', Hepatology, vol. 67, no. 3, pp. 837-846.


Goldstein, DA, Chen, Q, Ayer, T, Chan, KKW, Virik, K, Hammerman, A, Brenner, B, Flowers, CR & Hall, PS 2017, 'Bevacizumab for metastatic colorectal cancer: A global cost-effectiveness analysis', Oncologist, vol. 22, no. 6, pp. 694-699.
Aggarwal, R, Chen, Q, Goel, A, Seguy, N, Pendse, R, Ayer, T & Chhatwal, J 2017, 'Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India', PloS one, vol. 12, no. 5, e0176503.
Kohn, CG, Zeichner, SB, Chen, Q, Montero, AJ, Goldstein, DA & Flowers, CR 2017, 'Cost-effectiveness of immune checkpoint inhibition in BRAF wild-type advanced melanoma', Journal of Clinical Oncology, vol. 35, no. 11, pp. 1194-1202.
Chen, Q, Jain, N, Ayer, T, Wierda, WG, Flowers, CR, O'Brien, SM, Keating, MJ, Kantarjian, HM & Chhatwal, J 2017, 'Economic burden of chronic lymphocytic leukemia in the era of oral targeted therapies in the United States', Journal of Clinical Oncology, vol. 35, no. 2, pp. 166-174.
Chen, Q, Jain, N, Flowers, CR & Chhatwal, J 2017, 'Reply to C. Nabhan et al', Journal of Clinical Oncology, vol. 35, no. 16, pp. 1864-1865.
Kohn, CG, Zeichner, SB, Chen, Q, Montero, AJ, Flowers, CR & Goldstein, DA 2017, 'Reply to Á. Benedict et al', Journal of Clinical Oncology, vol. 35, no. 26, pp. 3086-3087.

Clinical Trials Search

Children (age < 18 years)
Adults (age >= 18 years)